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Abstract
 Obstructive sleep apnea (OSA) is a disorder that results in loud
snoring, gasping respirations, and excessive daytime sleepiness.
 OSA also has the potential to progress to other significant
diseases such as hypertension, diabetes mellitus, stroke, and
pulmonary hypertension.
 Continuous positive airway pressure (CPAP) has been the first
line treatment for OSA since the early 1980’s. Unfortunately,
despite the ability of CPAP to significantly improve symptoms
of OSA, a large amount of patients struggle to comply with this
treatment.
 A new alternative treatment for OSA is hypoglossal nerve
stimulation therapy (HGNS), resulting in an increase in muscle
tone to the oropharynx, keeping the airway patent during
inspiration.
 This review of the literature will examine the efficacy and
compliance rates of CPAP, as well as the safety and efficacy of
HGNS.
 Research found that there is in fact a need for an alternative
therapy for OSA due to high CPAP noncompliance rates.
 The findings also indicate that despite favorable outcomes in
clinical trials, more research is needed to determine the
prolonged safety and efficacy of HGNS surgery.

Introduction

Research Questions
 How significant is noncompliance to CPAP treatment?
 In patients diagnosed with OSA who are intolerant of CPAP, is
hypoglossal nerve stimulation therapy a safe and efficacious
alternative treatment?

Literature Review
Epidemiology and Pathophysiology of OSA
 OSA is defined as the repetitive obstruction of the upper airway
tissues during inspiration, resulting in an obstructed airway
during sleep.
 Physical exam will most commonly show obesity, large neck
circumference, sleepiness, and/or nasal-sounding speech.
 Lee et al. 2008 suggests up to 80% of moderate to severe OSA
sufferers are thought to be undiagnosed.

 Diagnosis and severity is made with polysomnography while
measuring the apnea/hypoapnea index (AHI).
 Several clinical studies are referenced which show the efficacy
of CPAP versus current alternative treatments, as well as the
efficacy and safety of hypoglossal nerve stimulation.

Hypoglossal Nerve Stimulation Therapy
 HGNS is a new procedure where a stimulating device, similar to
a pacemaker, is implanted in the chest and connected to the
hypoglossal nerve, thus stimulating the genioglossus muscle
(shown in Figure 2).

 There is a significant need for a reliable alternative treatment for
OSA when patients are intolerant of CPAP therapy and oral
appliances.
 Papadakis & McPhee, 2014 explains that only about 75% of
patients continue to use their CPAP device after the first year.

 Obesity is the largest contributing factor in the development of
OSA. It is broadly understood that the best management is
prevention through healthy diet and regular exercise.
 CPAP is found to be very effective in patients who are able to
tolerate the many disabling side effects.
 In order to increase the compliance rates of CPAP, patients need
accessibility and education regarding the use and management
of CPAP.
 As for all other diseases, a safe and efficacious alternative
treatment is necessary for those who do not comply with CPAP.
 As Figure 3 illustrates, HGNS appears to be capable of creating
a more patent airway compared to no treatment.
 HGNS therapy showed success in subjective and objective
testing in both studies referenced.
 However, more clinical research is necessary to guarantee the
efficacy, safety, and reliability of the product being used.

Figures

 Notable alternative treatments currently used are oral
mandibular devices and uvulopalatopharyngoplasty (UPPP).
 Common reasons for noncompliance of CPAP include
claustrophobia, mask leaks and skin irritation.

 OSA is a disorder that has a large variety of potential long term
complications.
 OSA is often easily recognized with a thorough history and
physical.

Statement of the Problem

Discussion

CPAP and Alternative Treatments for OSA
 CPAP, which is the first line treatment for OSA, is a nasal or
oral-nasal mask which pushes pressurized air upon inspiration.

 Doff et al. 2013 reports significant improvements in AHI with
CPAP and oral appliance therapy (as shown in Figure 1).
 27% of the 103 participants in the Doff et al. study were lost to
noncompliance or unsuccessful treatment with CPAP and oral
appliances.

 Two single-arm, open-label studies evaluated patients with
moderate to severe OSA who underwent HGNS surgery;
compliance (hours used per night), safety (adverse events), AHI,
and several subjective symptoms were assessed.
 Eastwood et al. studied 21 participants who underwent HGNS
implantation; of the 19 who completed the study, improvement
was made as AHI was reduced from 43.1 ± 17.5 to 19.5 ± 16.7.
 Similarly, a study from Mwenge, Rombaux, Dury, Lengele, &
Rodenstein followed 13 participants following successful HGNS
implantation; AHI improved from 45.2 ± 17.8 to 21.0 ± 16.5.
 Notable adverse events for the two studies include one patient
with hematoma and infection, two patients with ipsilateral hemitongue paresis with full recovery, and one patient with postoperative swelling.
 Defective equipment were noted between the two studies
including broken leads and a failed pulse generator.

Applicability to Clinical
Practice
 Obstructive sleep apnea is a disease that is rapidly increasing in
incidence, yet is relatively unknown to the general public.
 Providers need to be screening and catching this “not-so-silent
killer” before it manifests into other significant comorbidities or
a fatal accident.
 CPAP alternatives, such as oral mandibular devices and UPPP,
often create their own significant side effects and are usually
less effective.
 Instead of cycling between these treatments, extensive education
is necessary for the compliance of CPAP. This includes finding
an appropriately fitting mask and appropriate pressure settings.
 Despite favorable outcomes in the clinical studies for HGNS
therapy, it is considered an extremely invasive alternative
treatment.
 HGNS is in the very early stages to the road toward being a
feasible alternative to CPAP, as there are very few physicians
trained in the procedure or equipment.
 Considering the lack of research for HGNS, providers
should be exhausting all efforts into assuring patients are
adequately educated about the benefits of CPAP, including
ways to overcome its many side effects.
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